What determines the switch between atrophic and neovascular forms of








































Age-related macular degeneration (AMD) is the leading 
cause of irreversible blindness in the elderly [1-2]. 
Considerable evidence supports the opinion that the 
retinal pigment epithelium (RPE), a monolayer of cells 
between the light sensitive photoreceptors and the 
vascular choroid, is a primary site of pathology in the 
disease [1-5]. The RPE provides support for the 
photoreceptors and plays a critical role in the visual 
cycle; thus, degeneration and loss of RPE lead to 
secondary degeneration of photoreceptor cells [3]. Early 
AMD is characterized by the presence of extracellular 
deposits, or drusen, beneath the RPE. Increasing 
numbers of large drusen predispose to the development 
of the late blinding forms ofe disease which n 
manifest 
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in two disparate ways. In late, “dry” AMD, geographic 
loss of RPE occurs in the macular region, while in the 
late neovascular or “wet” form of the disease, there is 
abnormal growth of choroidal vessels under the retina 
which leak fluid and may progress to form a disciform 
scar (Figure 1) [1-5]. Pathogenic mechanisms for AMD 
include both genetic and environmental
 factors related 
to primary RPE senescence, alterations in the 
complement pathway, increased inflammation, changes 
in the balance of growth factors, excessive lipofuscin
 
accumulation, and oxidative stress [5]. Major genetic 
risk factors for AMD, including Complement Factor H 
and HTRA1 variants, appear to predispose to both 
atrophic and neovascular AMD [6, 7]; only recently has 
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predisposes to the atrophic form [8]. Consequently, 
there is considerable interest in further establishing the 
factors that mediate the “molecular switch” that may 
determine which late form of the disease an individual 
develops.  
 
Recently, we reported that bone morphogenetic protein 
(BMP)4 is prominently expressed in the RPE and 
adjacent extracellular matrix of patients with the dry or 
atrophic form of AMD when compared to controls 
(Figure 2A, B). Here, we show that in the wet or 
neovascular form of the disease (5 patients with surgical 
excision of choroidal neovascular membranes due to 
neovascular AMD) there is almost no expression of 
BMP4 in the RPE and adjacent neovascular tissues 
(Figure 2C). Interestingly, in cases (3 patients) in which 
the neovascular lesion had progressed to a fibrous scar, 
the level of BMP4 expression increased in the RPE and 
adjacent tissues (Figure 2D). This has led us to the 


































cipating in the pathway decision that determines which 
form of late AMD develops.  
 
BMP4 is an important regulator of differentiation, 
senescence and apoptosis in many different cells and 
tissues [9, 10]. We reported that BMP4 can induce RPE 
senescence  in vitro [11], and that RPE chronically 
exposed to sublethal doses of oxidative stress can 
increase their BMP4 expression and exhibit a senescent 
phenotype, thus supporting the contention that BMP4 
mediates oxidative stress-induced RPE senescence.  We 
further determined that BMP4 mediates RPE 
senescence via activation of Smad and p38 pathways to 
activate p53, and increase expression of p21
WAF1/ cip1, 
and to decrease phospho-Rb. Importantly, BMP4-
mediated RPE senescence can be inhibited by Chordin-
like, a BMP4 antagonist, and SB203580, a phospho-p38 
inhibitor. Our findings not only disclose a molecular 
pathway linking oxidative stress with RPE senescence, 
but also provide a novel therapeutic target for treatment 



















































































Recently, Demidenko et al. [12] evaluated the concept 
that duration of cell cycle arrest determines the 
progressive loss of proliferative capacity characteristic 
of cellular senescence [12].  Using a variety of cell lines 
including the spontaneously immortalized human RPE 
cell line, ARPE-19, they found that rapamycin, an 
inhibitor of the nutrient-sensor mammalian target of 
rapamycin (mTOR), partially prevented loss of 
proliferative potential induced by oxidative stress, or 
ectopic p21 or p16 exposure, leading to deceleration of 
cellular senescence [12].  This work supports the critical 
role of oxidative stress, and cell cycle arrest in induction 
of senescence and demonstrates a pharmacologic 
approach to suppression of RPE senescence [12]. 
 
Interestingly, BMP4 has been found to be involved in 





































for  BMP4  (red  chromogen)  in  retinal  pigment  epithelium  (RPE)/choroid  tissue  sections  from  donor  eyes  with
hematoxylin counterstain. In (A) a control individual without AMD shows no apparent BMP4 staining in RPE or choroid.












cancer cells [13]. Adriamycin and BMP4 treatment can 
induce lung cancer cell senescence, and BMP4 
expression is increased in Adriamycin-treated lung 
cancer cells. This BMP4-induced premature senescence 
is mediated through Smad signaling to up-regulate 
p16
INK4a and p21
WAF1/ cip1.  BMP4 and other BMP 
signaling pathways were also found to participate in 
senescence of multiple cancer cell types or in the 
inhibition of tumor cell growth [14, 15]. For example, 
BMP-2 and -4 inhibit prostate cancer cell growth through 
Smad-1 phosphorylation, p21
WAF1/ cip1 up-regulation, and 
Rb dephosphorylation, while in glioblastoma, BMP4 and 
its cognate receptors can trigger the Smad signaling 
cascade to reduce the proliferation of  tumor cells [16]. 
Together, these studies reveal that BMP4 induces and 
mediates the premature senescence of both malignant 
cells in tumors and aging RPE cells in dry AMD. 
 
 


























Transforming growth factor (TGF)-β has been 
extensively reported to be involved in mediating 
oxidative stress induced premature senescence of 
fibroblasts [17-19]. Recently it has been reported that 
TGF-β mediates oxidative stress induced RPE cell 
senescence through the up-regulation of p21
 WAF1/ cip1 
and the down-regulation of phosphorylated Rb and that 
blockade of TGF-β signaling by specific TGF-β 
antibody can impede RPE senescence [20]. This finding 
is similar to our finding for BMP4 mediated oxidative 
stress-induced RPE senescence. We suggest that TGF-β 
and BMP4 may have a synergistic effect in mediating 
the oxidative stress-induced RPE senescence, because 
neither TGF-β antibodies nor BMP4 antagonist alone 
can completely block the expression of senescence 
marker genes to baseline in the oxidative stress treated 
RPE cells. More investigations are needed to elucidate 
the interactions between TGF-β and BMP signaling 
cascades in oxidative stress-induced RPE senescence. 
 
A variety of intrinsic and extrinsic stress signals can 
activate the p53 pathway, which then triggers either 
cellular senescence or apoptosis [21, 22]. We found that 
both BMP4 and oxidant treatment can increase p53 
protein level in RPE cells. A microarray analysis of the 
RPE transcriptome from the maculas of six healthy, 
elderly human donors revealed a statistically significant 
overrepresentation of genes associated with stress, with 




































RPE genes [23]. Although little is known about how 
p53 regulates cellular senescence and how p53 interacts 
with the BMP-Smad pathway, the fact that p53 levels 
were increased in RPE cells after BMP4 treatment and 
Smad1/5 could bind to p53 [24], raises the possibility 
that Smad1/5 activates p53 dependent transcription 
through the regulation of post-translational 
modifications of p53, such as phosphorylation and 
acetylation. 
 
It remains unanswered why some patients develop 
atrophic AMD while others develop the neovascular 
form of the disease. The switch between dry and wet 
AMD may be related to differences in the 
microenvironment created by senescent RPE cells, 
which secrete a number of cytokines and growth factors 
[25]. The defined components of this “senescence 
associated secretory phenotype” (SASP) include 
elements associated with inflammation, and 
angiogenesis, such as interleukin (IL)-6 and IL-8 [26-
28]. We have found that RPE cells induced into 
senescence by chronic oxidative stress secrete 4 times 
higher IL-8 than non-senescent RPE cells (Figure 3). 
IL-8 promotes angiogenesis by increasing the 
proliferation, survival and migration of endothelial cells 
and promotes inflammation by increasing neutrophil 
chemotaxis and degranulation [29-31]. Together these 
findings suggest that chronic oxidative stress increases 
the premature senescence of RPE. If RPE do not go 
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senescent RPE may secrete high levels of IL-8, which in 
turn stimulate inflammation and angiogenesis. But what 
about the finding that neovascular AMD lesions show 
minimal levels of BMP4? In other cell types, pro-
inflammatory mediators such as tumor necrosis factor 
(TNF)-alpha have been shown to downregulate BMP4 
expression [32]. In the absence of BMP4, neovascular 
endothelial cells, stimulated by increased expression of 
vascular endothelial growth factor, and without the 
growth inhibitory senescence and cell death effects 
mediated by BMP4, would be in a permissive environ-
ment for angiogenesis [5]. This idea is further supported 
by the finding that when neovascular AMD lesions 
undergo subsequent scar formation, with degeneration 
and loss of neovascular endothelial cells, there is a 
concomitant increase in BMP4 expression (Figure 2). 
 
It has been previously observed that tissues in aged 
individuals may exhibit the paradoxical juxtaposition of 
atrophy and hyperplasia within the same tissue or even 
within the same cell type [33]. This response may be 
explained in part by senescent heterogeneity [34, 35]. In 
vitro culture of human fibroblasts results in a fraction of 
cells senescing at every population doubling. The 
senescent cells have shorter telomeres than their cycling 
counterparts. Thus, it was concluded that the main cause 
of intrinsic heterogeneity of senescent fibroblasts was 
the cell to cell variation of telomere shortening [36]. 
Using pulse-chase 5-bromodeoxyuridine-labeling assay, 
Gonzalez and colleagues revealed that the senescent 
heart contained functionally competent cardiac 
progenitor cells (CPCs) with longer telomeres, and 
these stem cell-like CPCs can be activated and migrate 
to the damaged regions to generate a population of 
young cardiomyocytes and partly reverse the aging 
myopathy [37].   
 
Much remains to be learned about the genetic and 
environmental factors mediating the progression of 
early AMD to its late forms. Our finding of differential 
expression of BMP4 in geographic atrophy and 
neovascular AMD and the interactive roles of oxidative 
stress, inflammation and senescence in the regulation 
and functional effects of this growth factor, suggests the 
possibility that BMP4 may be playing a part in the 
molecular switch determining which phenotypic 
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